Advertisement
Home Tags Xolair

Tag: Xolair

For patients with a significant response to allergen challenge

Omalizumab Protects Against Early, Late Allergic Responses

Significant reduction in early allergic reaction after 4 weeks, with decrease in FEV1, exhaled nitric oxide